Evidence map›Paper›PMID 37210530›Full record

ArticleJournal of nanobiotechnology2023

Novel plant-derived exosome-like nanovesicles from Catharanthus roseus: preparation, characterization, and immunostimulatory effect via TNF-α/NF-κB/PU.1 axis.

Xiaozheng Ou, Haoran Wang, Huilin Tie, Jiapei Liao, Yuanyuan Luo, Weijuan Huang, Rongmin Yu, Liyan Song, Jianhua Zhu

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 2 pooled it
25.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 2 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Natural Product-Derived Vesicles in Nanotherapeutics.Journal of extracellular vesicles · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaozheng Ou *Biotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou, 511443, China.
Haoran Wang *Weihai Neoland Biosciences Co., Ltd, Weihai, 264209, China.
Huilin TieBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou, 511443, China.
Jiapei LiaoBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou, 511443, China.
Yuanyuan LuoDepartment of Pharmacology, Jinan University, Guangzhou, 511443, China.
Weijuan HuangDepartment of Pharmacology, Jinan University, Guangzhou, 511443, China.
Rongmin YuBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou, 511443, China. tyrm@jnu.edu.cn.
Liyan SongDepartment of Pharmacology, Jinan University, Guangzhou, 511443, China. tsly@jnu.edu.cn.
Jianhua ZhuBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou, 511443, China. tzhujh@jnu.edu.cn.
Jinan University · CNWeihai Science and Technology Bureau · CN

Funding

Guangdong Province Natural Science Fund for Distinguished Young Scholars 2016A030306009Guangzhou Science and Technology Plan Project 202201010107National Natural Sciences Foundation of China 81274045National Natural Sciences Foundation of China 81673571
6 · The paper itself

Abstract

backgroundPlant-derived exosomes-like nanovesicles (PDENs) have been found to be advantageous in disease treatment and drug delivery, but research on their biogenesis, compositional analysis, and key marker proteins is still in its infancy, which limits the standardized production of PDENs. Efficient preparation of PDENs continues to be a major challenge.

resultsNovel PDENs-based chemotherapeutic immune modulators, Catharanthus roseus (L.) Don leaves-derived exosome-like nanovesicles (CLDENs) were isolated from apoplastic fluid. CLDENs were membrane structured vesicles with a particle size of 75.51 ± 10.19 nm and a surface charge of -21.8 mV. CLDENs exhibited excellent stability, tolerating multiple enzymatic digestions, resisting extreme pH environments, and remaining stable in the gastrointestinal simulating fluid. Biodistribution experiments showed that CLDENs could be internalized by immune cells, and targeted at immune organs after intraperitoneal injection. The lipidomic analysis revealed CLDENs' special lipid composition, which contained 36.5% ether-phospholipids. Differential proteomics supported the origin of CLDENs in multivesicular bodies, and six marker proteins of CLDENs were identified for the first time. 60 ~ 240 μg/ml of CLDENs promoted the polarization and phagocytosis of macrophages as well as lymphocyte proliferation in vitro. Administration of 20 mg/kg and 60 mg/kg of CLDENs alleviated white blood cell reduction and bone marrow cell cycle arrest in immunosuppressive mice induced by cyclophosphamide. CLDENs strongly stimulated the secretion of TNF-α, activated NF-κB signal pathway and increased the expression of the hematopoietic function-related transcription factor PU.1 both in vitro and in vivo. To ensure a steady supply of CLDENs, plant cell culture systems of C. roseus were established to provide CLDENs-like nanovesicles which had similar physical properties and biological activities. Gram-level nanovesicles were successfully obtained from the culture medium, and the yield was three times as high as the original.

conclusionsOur research supports the use of CLDENs as a nano-biomaterial with excellent stability and biocompatibility, and for post-chemotherapy immune adjuvant therapy applications.

Indexed as

CatharanthusExosomesAnimalsMiceNF-kappa BTissue DistributionTumor Necrosis Factor-alphaNF-kappa BTumor Necrosis Factor-alphaCatharanthus roseus (L.) DonImmunostimulationPlant cell culture technologyPlant-derived exosome-like nanovesicles

Identifiers

PMID37210530
PMCPMC10199296
OpenAlexW4377157326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.